We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
CSL Rh(D) IMMUNOGLOBULIN VF (human) 250 IU injection vial, CSL Behring Australia, CON-406
Product name
CSL Rh(D) IMMUNOGLOBULIN VF (human) 250 IU injection vial
Sponsor name
CSL Behring Australia
Consent start
Consent no.
CON-406
Duration
The consent is effective from the 30th April 2020 until further notice.
Standard
Paragraph 8(1)(c) and subparagraphs 10(3)(a)(i) and 11(2)(f)(v) in the Therapeutic Goods Order No. 91 - Standard for labels of prescription and related medicines
Non-compliance with standard
1.The product’s carton does not express the quantity or proportion of all active
ingredients as the weight in the stated volume of fill in the container.2. The
product’s carton does not express the quantity of the excipient as the mass in
the stated volume of fill in the container.3. The product’s carton does not
state the weight of the active ingredient in the stated volume of fill of the
injection in the container.
Conditions imposed
The carton exempted from TGO 91 is identical to that approved by the
TherapeuticGoods Administrationand presented with thesubmission.
Import, Supply, &/or Export
Supply
Therapeutic product type
Prescription medicines